Monthly Archives: March 2014

Prana’s AD Gamble Falls Short

Prana just reported that PBT2 did not produce benefit vis-a-vis AB plaque load, cognition, or metabolic function in their latest Phase II trial in prodromal/mild Alzheimer’s. A nonsignificant trend towards slowed hippocampal atrophy (2.6% vs. 4.2%) over twelve months was … Continue reading

Posted in BioFollies, Biotech | Tagged , , | Leave a comment

Zohydro’s Days are Numbered

(A courtroom in the United States, December 2016) “Doctor…Why did you prescribe Zohydro to the plaintiff’s son in July 2015?” “He was experiencing severe pain as a result of his fall, and I had positive experience in using Zohydro with … Continue reading

Posted in BioFollies, Biotech | Tagged , , , , , | 1 Comment